# An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System

> **NCT04029337** · NA · RECRUITING · sponsor: **HighLife SAS** · enrollment: 30 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** Transcatheter Mitral Valve Replacement

## Key facts

- **NCT ID:** NCT04029337
- **Lead sponsor:** HighLife SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-14
- **Primary completion:** 2025-12
- **Final completion:** 2030-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04029337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04029337, "An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04029337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*